Posts detected
52
1.7 per day on average
Live account profile
@adamfeuerstein
Tier: Fast
@adamfeuerstein is a widely followed public account. Traders typically monitor this account for headline-driven sentiment changes that can create short-term trading opportunities. In the last 30 days, its content clustered around general updates.
Last 30 days: 52 detected posts, median alert timing 653ms, and latest detected post at Apr 16, 2026, 1:48 PM UTC. This is about 403ms slower than our ~250ms baseline.
Source profile: https://x.com/adamfeuerstein
52
1.7 per day on average
5
posts in last 24h (52 in last 7d)
653ms
p95: 1,068ms
108
avg chars per detected post
These values show how quickly alerts typically fire after a post appears. Use them to judge whether this account fits fast-reaction or slower confirmation strategies.
151ms
653ms
661ms
1,068ms
1,365ms
Peak windows: 11:00-12:00 UTC, 12:00-13:00 UTC, 03:00-04:00 UTC.
Active on 4 distinct days in the current 30-day window.
Data freshness date: 2026-04-17. Terms are recalculated from the most recent 30-day window.
These snippets come from recent detected posts for this handle. Each row includes post time, alert time, and measured delay.
Right, it's "data" and can be useful in that regard. But showing a single patient is selective.
Funny how you never see the videos of kids who can't walk up stairs or get up from the floor after taking a gene therapy. Sure, videos like the one shared by $SLDB and previously by $SRPT are heartwarming and encouraging, but they are not data.
This week's Biotech Scorecard newsletter: $TVTX Travere Therapeutics' drug for a rare kidney disease doesn’t improve kidney function. The FDA approved it anyway.
Roche to launch another Elevidys trial, with eyes on European approval via @DrewQJoseph $SRPT
$ANL What time yesterday did the bankers start making calls about the PIPE?
And in the nearly two decades since that report was issued, many efforts to develop IL-15 based cancer drugs have been tried and failed. Look at the list, some of those targets have worked, others have not. Keytruda, a PD-1 inhibitor, is the best-selling cance
This Bayern - Real Madrid match is insane.
in other words, pray we don't get mean reversion?
@adamfeuerstein is a widely followed public account. Traders typically monitor this account for headline-driven sentiment changes that can create short-term trading opportunities. In the last 30 days, its content clustered around general updates.
This section is written for traders: who this account represents and why its posts can matter for markets.
Stats come from the rolling 30-day window and update as new posts are detected. Current freshness date: 2026-04-17.
Yes. ProfileTracer supports HTTP webhooks plus native formatting for Slack and Discord destinations.
Informational use only. ProfileTracer does not provide investment advice. Timing and content can vary based on upstream platform behavior, account activity, and destination delivery conditions.